Verition Fund Management LLC Reduces Stake in Omega Healthcare Investors, Inc. (NYSE:OHI)

Verition Fund Management LLC decreased its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 54.8% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 16,911 shares of the real estate investment trust's stock after selling 20,492 shares during the quarter. Verition Fund Management LLC's holdings in Omega Healthcare Investors were worth $688,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of OHI. Assetmark Inc. raised its holdings in shares of Omega Healthcare Investors by 1.7% during the third quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust's stock valued at $48,492,000 after purchasing an additional 19,542 shares during the last quarter. BNP Paribas Financial Markets grew its position in Omega Healthcare Investors by 120.8% in the 3rd quarter. BNP Paribas Financial Markets now owns 226,338 shares of the real estate investment trust's stock worth $9,212,000 after purchasing an additional 123,836 shares during the period. Daiwa Securities Group Inc. raised its stake in Omega Healthcare Investors by 317.7% during the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust's stock valued at $160,739,000 after buying an additional 3,003,845 shares during the last quarter. Caxton Associates LP bought a new position in shares of Omega Healthcare Investors during the 2nd quarter valued at $1,652,000. Finally, Van ECK Associates Corp boosted its stake in shares of Omega Healthcare Investors by 15.4% in the 3rd quarter. Van ECK Associates Corp now owns 100,145 shares of the real estate investment trust's stock worth $4,167,000 after buying an additional 13,367 shares during the last quarter. Institutional investors own 65.25% of the company's stock.

Insider Buying and Selling

In other news, CFO Robert O. Stephenson sold 22,542 shares of the firm's stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the business's stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts recently commented on the company. BNP Paribas upgraded Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price objective for the company in a research report on Thursday, October 31st. BMO Capital Markets raised shares of Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 price target for the company in a research report on Monday. Berenberg Bank initiated coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They issued a "buy" rating and a $45.00 price objective on the stock. Truist Financial boosted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a research report on Wednesday, September 4th. Finally, Royal Bank of Canada increased their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a research report on Monday, November 11th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, Omega Healthcare Investors has an average rating of "Moderate Buy" and an average price target of $40.18.

Omega Healthcare Investors Price Performance

Shares of NYSE OHI traded down $0.37 during midday trading on Wednesday, reaching $38.90. The stock had a trading volume of 2,016,136 shares, compared to its average volume of 1,688,196. The company has a market capitalization of $10.50 billion, a price-to-earnings ratio of 28.60, a price-to-earnings-growth ratio of 1.22 and a beta of 0.98. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $44.42. The stock has a 50-day moving average of $40.41 and a 200-day moving average of $37.81. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were paid a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.89%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors's dividend payout ratio (DPR) is 197.06%.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.